Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Ultrasound-facilitated, Catheter-directed, Thrombolysis Versus Anticoagulation for Acute Intermediate-high Risk Pulmonary Embolism: The Higher-risk Pulmonary Embolism Thrombolysis Study

NCT04790370 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04790370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04790370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Ultrasound-facilitated, Catheter-directed, Thrombolysis Versus Anticoagulation for Acute Intermediate-high Risk Pulmonary Embolism: The Higher-risk Pulmonary Embolism Thrombolysis Study
Lead sponsor
Boston Scientific Corporation
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 2, 2021
Completion date
August 31, 2026
Enrollment
544 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism